AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32738795 — intervention group
Group type: COMPARATOR
Intervention: Fenestrated screws augmented with polymethylmethacrylate
Number of subjects: 40
Study 34561181 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous wound infusion (CWI) with ropivacaine 1% (1 mg kg–1 + 0.8 mg kg–1 hour–1)
Number of subjects: 38
Study 34561181 — intervention group
Group type: COMPARATOR
Intervention: Epidural administration of ropivacaine 0.5% (1.3 mg kg–1) and morphine (0.1 mg kg–1)
Number of subjects: 38
Study 35609816 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS)
Number of subjects: 60
Study 35609816 — intervention group
Group type: COMPARATOR
Intervention: 10 Hz high-frequency repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 60
Study 33605002 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional botulinum toxin type-A (BTX-A) injection
Number of subjects: 60
Study 33605002 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional platelet rich plasma (PRP) injection
Number of subjects: 60
Study 33605002 — intervention group
Group type: COMPARATOR
Intervention: Intralesional triamcinolone acetonide (TAC) injection
Number of subjects: 60
Study 34690012 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message intervention (reminder and informational texts); reminder texts once per day, informational texts three times per week for 45 days
Number of subjects: 101
Study 34645365 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined action observation and motor imagery training (AO+MI training)
Number of subjects: 96
Study 34645365 — intervention group
Group type: COMPARATOR
Intervention: Physical training
Number of subjects: 96
Study 32360399 — intervention group
Group type: EXPERIMENTAL
Intervention: C-HIIT (supervised combined high-intensity interval training)
Number of subjects: 32
Study 32360399 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MICT (supervised combined aerobic and resistance moderate-intensity continuous training)
Number of subjects: 32
Study 32360399 — intervention group
Group type: COMPARATOR
Intervention: C-HIIT
Number of subjects: 32
Study 32360399 — intervention group
Group type: COMPARATOR
Intervention: C-MICT
Number of subjects: 32
Study 32360399 — intervention group
Group type: EXPERIMENTAL
Intervention: C-HIIT and C-MICT
Number of subjects: 32
Study 35120640 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent treatment (4-days-on and 3-days-off regimen)
Number of subjects: 636
Study 35120640 — intervention group
Group type: COMPARATOR
Intervention: Continuous treatment (7-day regimen)
Number of subjects: 636
Study 35120640 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent treatment
Number of subjects: 636
Study 35120640 — intervention group
Group type: COMPARATOR
Intervention: Continuous treatment
Number of subjects: 636
Study 33790017 — intervention group
Group type: EXPERIMENTAL
Intervention: Deworming treatment (two to three additional years)
Number of subjects: 0
Study 35404725 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS plus Matrix psychotherapy (n=15)
Number of subjects: 60
Study 35404725 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS plus Matrix psychotherapy (n=12)
Number of subjects: 60
Study 35404725 — intervention group
Group type: COMPARATOR
Intervention: Matrix psychotherapy only (n=13)
Number of subjects: 60
Study 35404725 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 34463288 — intervention group
Group type: EXPERIMENTAL
Intervention: KIO015
Number of subjects: 22
Study 34463288 — intervention group
Group type: COMPARATOR
Intervention: HA-based device
Number of subjects: 22
Study 32831212 — intervention group
Group type: EXPERIMENTAL
Intervention: Basketball-specific 8-week balance training group (BTG)
Number of subjects: 31
Study 32831212 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 31
Study 35305341 — intervention group
Group type: EXPERIMENTAL
Intervention: avalglucosidase alfa
Number of subjects: 0
Study 35305341 — intervention group
Group type: COMPARATOR
Intervention: alglucosidase alfa
Number of subjects: 0
Study 33876436 — intervention group
Group type: EXPERIMENTAL
Intervention: SMAQ-12 (12-item short-form self-management ability questionnaire)
Number of subjects: 480
Study 33876436 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA)
Number of subjects: 480
Study 33275544 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol drink calibrated to reach approximately .050%, .075%, or .100% blood alcohol concentration
Number of subjects: 210
Study 33275544 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink condition
Number of subjects: 210
Study 35939083 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin-assisted therapy (n = 27)
Number of subjects: 1226
Study 35939083 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram (n = 25)
Number of subjects: 1226
Study 35939083 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychedelic experience (general)
Number of subjects: 1226
Study 34331678 — intervention group
Group type: EXPERIMENTAL
Intervention: Daridorexant 50 mg
Number of subjects: 36
Study 34331678 — intervention group
Group type: EXPERIMENTAL
Intervention: Daridorexant 200 mg
Number of subjects: 36
Study 34331678 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 36
Study 34331678 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 32267056 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual mitral regurgitation (rMR) ≤ 1+ at discharge (n = 251)
Number of subjects: 458
Study 32267056 — intervention group
Group type: COMPARATOR
Intervention: Residual mitral regurgitation (rMR) 2+ at discharge (n = 173)
Number of subjects: 458
Study 32267056 — intervention group
Group type: COMPARATOR
Intervention: Residual mitral regurgitation (rMR) ≥ 3+ at discharge (n = 34)
Number of subjects: 458
Study 32267056 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable rMR ≤ 1+ grades within 12 months
Number of subjects: 458
Study 35664502 — intervention group
Group type: EXPERIMENTAL
Intervention: ReSET intervention (3 face-to-face sessions and telephone coaching)
Number of subjects: 0
Study 35664502 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 32744034 — intervention group
Group type: EXPERIMENTAL
Intervention: RBX Chinese herbal tablets (CHT)
Number of subjects: 165
Study 32744034 — intervention group
Group type: COMPARATOR
Intervention: RBX Chinese formula granules (CFG)
Number of subjects: 165
Study 36038439 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Laryngoscope (VL) group (n = 186)
Number of subjects: 363
Study 36038439 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (C group; n = 177)
Number of subjects: 363
Study 33436442 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs, continuous thoracic epidural analgesia, subcostal transversus abdominis plane (TAP) blocks
Number of subjects: 0
Study 33436442 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen and non-steroidal anti-inflammatory drugs combined with thoracic epidural analgesia or bilateral oblique subcostal TAP blocks
Number of subjects: 0
Study 33436442 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic opioids
Number of subjects: 0
Study 33436442 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine, intravenous magnesium, intrathecal morphine, quadratus lumborum blocks, paravertebral nerve blocks, continuous local anesthetic wound infiltration, postoperative interpleural local anesthesia
Number of subjects: 0
Study 33436442 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine, ketamine, dexamethasone, gabapentinoids
Number of subjects: 0
Study 36039038 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime-MIP
Number of subjects: 36
Study 36039038 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime Sandoz
Number of subjects: 36
Study 36039038 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid Kabi
Number of subjects: 36
Study 36039038 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin Kabi
Number of subjects: 36
Study 36039038 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin Aurobindo
Number of subjects: 36
Study 36039038 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazobactam Kabi
Number of subjects: 36
Study 36039038 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazobactam Aurobindo
Number of subjects: 36
Study 33894832 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation (0.8 mA, 100 μs, 30 Hz stimulation pulses, lasting 0.5 s) paired with rehabilitation (6 weeks of in-clinic therapy, three times per week, followed by home exercise programme)
Number of subjects: 108
Study 33894832 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation paired with rehabilitation
Number of subjects: 108
Study 33894832 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation paired with rehabilitation (0 mA pulses)
Number of subjects: 108
Study 33894832 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation paired with rehabilitation
Number of subjects: 108
Study 35754192 — intervention group
Group type: EXPERIMENTAL
Intervention: Red meat consumption intervention
Number of subjects: 12
Study 35754192 — intervention group
Group type: EXPERIMENTAL
Intervention: Red meat metabolite score
Number of subjects: 12
Study 33840631 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased FV intake by 3 or more servings
Number of subjects: 1165
Study 33840631 — intervention group
Group type: COMPARATOR
Intervention: No change or decrease in FV intake
Number of subjects: 1165
Study 35930254 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO STOPS intervention
Number of subjects: 1406
Study 35930254 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1406
Study 32929215 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 33
Study 32929215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 32448299 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBIND intervention (integrated mHealth application with PMTCT educational videos, SMS alerts, personal empowerment and motivational interviewing training)
Number of subjects: 30
Study 32448299 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBIND intervention (personal empowerment training with motivational interviewing skills)
Number of subjects: 30
Study 32448299 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBIND intervention (mHealth application)
Number of subjects: 30
Study 32448299 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBIND intervention (SMS appointment alerts)
Number of subjects: 30
Study 32448299 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBIND intervention
Number of subjects: 30
Study 34526092 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple randomization
Number of subjects: 11832
Study 34526092 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate-constrained randomization using 11 prognostic characteristics
Number of subjects: 11832
Study 34526092 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate-constrained randomization using principal components from 29 baseline historical variables
Number of subjects: 11832
Study 32601075 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin-Paclitaxel-Trastuzumab (T)
Number of subjects: 61
Study 32601075 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin-Paclitaxel (Control)
Number of subjects: 61
Study 36229710 — intervention group
Group type: EXPERIMENTAL
Intervention: Elacestrant (oral SERD)
Number of subjects: 0
Study 36229710 — intervention group
Group type: EXPERIMENTAL
Intervention: Other oral SERDs
Number of subjects: 0
Study 36229710 — intervention group
Group type: COMPARATOR
Intervention: SERMs or AIs
Number of subjects: 0
Study 32244777 — intervention group
Group type: EXPERIMENTAL
Intervention: EMS intervention (electromyostimulation combined with exercises and music)
Number of subjects: 25
Study 32244777 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 25
Study 35953430 — intervention group
Group type: EXPERIMENTAL
Intervention: Photochromic contact lens (ACUVUE® OASYS with Transitions™ Light Intelligent Technology™)
Number of subjects: 250
Study 35953430 — intervention group
Group type: COMPARATOR
Intervention: Non-photochromic control lens (ACUVUE® OASYS 2‐week with HYDRACLEAR® PLUS)
Number of subjects: 250
Study 33413287 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination practices among UMs
Number of subjects: 22
Study 33413287 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 22
Study 33413287 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV vaccine awareness
Number of subjects: 22
Study 33413287 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to vaccination information
Number of subjects: 22
Study 33413287 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult vaccination
Number of subjects: 22
Study 32180239 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-training group (N = 20) trained on a 1- (low load) & 3-back (high load) WM task
Number of subjects: 40
Study 32180239 — intervention group
Group type: COMPARATOR
Intervention: Control-training group (N = 20) performed a 0-back WM task
Number of subjects: 40
Study 615705753 — intervention group
Group type: EXPERIMENTAL
Intervention: ET‐EG (Explore Transplant@Home with educator-guided coaching)
Number of subjects: 561
Study 615705753 — intervention group
Group type: EXPERIMENTAL
Intervention: ET‐PG (Explore Transplant@Home, video-based, patient-guided program)
Number of subjects: 561
Study 615705753 — intervention group
Group type: COMPARATOR
Intervention: SOC (Standard of Care transplant education)
Number of subjects: 561
Study 34740884 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgotinib 200 mg (FIL200)
Number of subjects: 3691
Study 34740884 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgotinib 100 mg (FIL100)
Number of subjects: 3691
Study 34740884 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 3691
Study 34063409 — intervention group
Group type: EXPERIMENTAL
Intervention: Brahmi essence for 12 weeks
Number of subjects: 0
Study 32762340 — intervention group
Group type: EXPERIMENTAL
Intervention: OM-89 immunotherapy (6 mg), once daily for 3 months
Number of subjects: 49
Study 32762340 — intervention group
Group type: COMPARATOR
Intervention: Placebo, once daily for 3 months
Number of subjects: 49
Study 36452042 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + FIBRO‐On
Number of subjects: 225
Study 36452042 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + FIBRO‐Out
Number of subjects: 225
Study 36452042 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 225
Study 36452042 — intervention group
Group type: EXPERIMENTAL
Intervention: FIBRO‐On and FIBRO‐Out
Number of subjects: 225
Study 36452042 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life and costs
Number of subjects: 225
Study 33383206 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.8 % SDF + RMGIC + DD
Number of subjects: 80
Study 33383206 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 % GO + RMGIC + DD
Number of subjects: 80
Study 33383206 — intervention group
Group type: COMPARATOR
Intervention: Control group (unconditioned specimens)
Number of subjects: 80
Study 32501897 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene therapy for Lebers Congenital Amaurosis
Number of subjects: 0
Study 33258274 — intervention group
Group type: EXPERIMENTAL
Intervention: Nap (near darkness)
Number of subjects: 0
Study 33258274 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light (1,200 lx, 4,000 K at eye level)
Number of subjects: 0
Study 33258274 — intervention group
Group type: COMPARATOR
Intervention: Control (200 lx, 4,000 K at eye level)
Number of subjects: 0
Study 32574895 — intervention group
Group type: EXPERIMENTAL
Intervention: HARMONIC ACE® + 23 cm shears (HS)
Number of subjects: 20
Study 32574895 — intervention group
Group type: COMPARATOR
Intervention: Monopolar electrocautery (EC)
Number of subjects: 20
Study 34032803 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided internet delivered cognitive behavioural treatment (CBT) for insomnia
Number of subjects: 0
Study 34032803 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaning‐centred group psychotherapy targeting personal meaning for cancer survivors
Number of subjects: 0
Study 34032803 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet‐based CBT treatment for persons with diabetes with elevated depressive symptoms
Number of subjects: 0
Study 34032803 — intervention group
Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 0
Study 32621141 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nails
Number of subjects: 154
Study 32621141 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive plate osteosynthesis
Number of subjects: 154
Study 32621141 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixation of fibula
Number of subjects: 154
Study 32621141 — intervention group
Group type: COMPARATOR
Intervention: Plating of fibula
Number of subjects: 154
Study 34587358 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI633 supplementation (two tablets daily for 8 weeks)
Number of subjects: 0
Study 34587358 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34379443 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus Cisplatin (GP)
Number of subjects: 362
Study 34379443 — intervention group
Group type: COMPARATOR
Intervention: Fluorouracil plus Cisplatin (FP)
Number of subjects: 362
Study 32252100 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined muscle training (CombT)
Number of subjects: 0
Study 32252100 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 0
Study 32252100 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory muscle training (EMT)
Number of subjects: 0
Study 35791588 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound glycyrrhizin
Number of subjects: 100
Study 35791588 — intervention group
Group type: COMPARATOR
Intervention: Desloratadine citrate combined with compound glycyrrhizin
Number of subjects: 100
Study 34587253 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week portfolio diet of proposed anti-inflammatory foods (high intake of fatty fish, whole grains, fruits, nuts, and berries)
Number of subjects: 50
Study 34587253 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week portfolio diet of proposed anti-inflammatory foods
Number of subjects: 50
Study 34587253 — intervention group
Group type: COMPARATOR
Intervention: Control diet resembling a Western diet
Number of subjects: 50
Study 36242544 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism therapy using 20 dioptre prism lenses for repeated aiming for 12 sessions
Number of subjects: 74
Study 36242544 — intervention group
Group type: COMPARATOR
Intervention: Neutral lenses for aiming training (Control group)
Number of subjects: 74
Study 34444313 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental condition (disaster experience)
Number of subjects: 214
Study 34444313 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 214
Study 34444313 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality salience
Number of subjects: 214
Study 34444313 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude
Number of subjects: 214
Study 34026421 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization to receive a housing voucher
Number of subjects: 0
Study 34026421 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in school district (mediated effect)
Number of subjects: 0
Study 35794433 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Caudal Epidural Analgesia (PCCA)
Number of subjects: 100
Study 35794433 — intervention group
Group type: COMPARATOR
Intervention: Patient-Controlled Intravenous Analgesia (PCIA)
Number of subjects: 100
Study 35794433 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 33069847 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffold (BVS) plus guideline-directed medical therapy (GDMT)
Number of subjects: 182
Study 33069847 — intervention group
Group type: COMPARATOR
Intervention: GDMT alone
Number of subjects: 182
Study 33069847 — intervention group
Group type: EXPERIMENTAL
Intervention: BVS
Number of subjects: 182
Study 36437688 — intervention group
Group type: EXPERIMENTAL
Intervention: TRV027
Number of subjects: 30
Study 36437688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35268099 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Streptococcus salivarius K12)
Number of subjects: 31
Study 35268099 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 34464304 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative physical therapy education program
Number of subjects: 50
Study 34464304 — intervention group
Group type: COMPARATOR
Intervention: Routine preparation for the procedure (Control)
Number of subjects: 50
Study 34319914 — intervention group
Group type: EXPERIMENTAL
Intervention: Covert stroke (DWI-detected ischemic injury)
Number of subjects: 164
Study 34319914 — intervention group
Group type: COMPARATOR
Intervention: No covert stroke
Number of subjects: 164
Study 32621918 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine pretreatment
Number of subjects: 0
Study 32621918 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (Control)
Number of subjects: 0
Study 34112719 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooled (therapeutic hypothermia)
Number of subjects: 50
Study 34112719 — intervention group
Group type: COMPARATOR
Intervention: Non-cooled (no therapeutic hypothermia)
Number of subjects: 50
Study 34112719 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI (moderate/severe basal ganglia and thalami injury)
Number of subjects: 50
Study 34112719 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI (absent/equivocal signal in the posterior limb of the internal capsule)
Number of subjects: 50
Study 34112719 — intervention group
Group type: EXPERIMENTAL
Intervention: GMA (absent fidgety movements)
Number of subjects: 50
Study 34112719 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI (normal/mild BGT injury)
Number of subjects: 50
Study 34112719 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI (normal PLIC)
Number of subjects: 50